Integra Lifesciences Holdings (IART) Shares Outstanding (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Shares Outstanding (Entity) data on file, last reported at $92.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 20.55% year-over-year to $92.2 million; the trailing twelve-month figure through Mar 2026 stood at $92.2 million (up 20.55% YoY), and the FY2025 full-year result was $76.7 million, down 16.31% from the prior year.
• Shares Outstanding (Entity) rose to $92.2 million in Q1 2026, from $76.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $92.2 million in Q1 2026 to a low of $76.5 million in Q1 2025.
• A 5-year average of $87.6 million and a median of $90.8 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) decreased 16.42% in 2025 and grew 20.55% in 2026, its largest moves.
• Tracing IART's Shares Outstanding (Entity) over 5 years: stood at $90.5 million in 2022, then climbed by 0.49% to $90.9 million in 2023, then rose by 0.76% to $91.6 million in 2024, then decreased by 16.31% to $76.7 million in 2025, then increased by 20.22% to $92.2 million in 2026.
• Business Quant data shows IART's Shares Outstanding (Entity) at $92.2 million in Q1 2026, $76.7 million in Q4 2025, and $76.8 million in Q3 2025.